Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe ...

In a groundbreaking discovery, scientists have found that the birth of new brain cells in adults plays a key role in verbal ...

Temporal lobe attention deficit disorder (ADD ... which may allow them to access support. If an adult or child has more serious symptoms, it is important to seek help as soon as possible.

Neurona Therapeutics has gained $102m to support the advancement of its investigational cell therapy, NRTX-1001, into Phase III testing for drug-resistant mesial temporal lobe epilepsy (MTLE ... The ...

Findings were seen for patients with drug-resistant temporal lobe epilepsy. HealthDay News — Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug ...

The asset, dubbed NRTX-1001, is currently being tested in an open-label phase 1/2 trial among patients with drug-resistant mesial temporal lobe epilepsy ... in which adults with drug-resistant ...

Vaclav Kremen, Ph.D., Mayo Clinic researcher and co-lead author of the study The researchers monitored five patients with temporal lobe epilepsy throughout their DBS treatment. The system allowed ...

In The Mind Electric, the neurologist explores the roots of neurological disease and the narratives that shape medicine. You write about a patient who fabricated details about her surroundings ...

At final follow-up, 15 respondents (75%) reached Engel class I (no seizures) and 5 respondents (25%) reached Engel class II (rare, nondisabling seizures). HealthDay News — Medial temporal ...